{"name": "Delenex Therapeutics",
 "permalink": "delenex-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/delenex-therapeutics",
 "homepage_url": "http://www.delenex.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+41-44-730 5180",
 "description": "",
 "created_at": "Mon Nov 15 02:38:46 UTC 2010",
 "updated_at": "Wed May 04 02:04:54 UTC 2011",
 "overview": "\u003Cp\u003EDelenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company\u0026#8217;s fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically validated technology delivers antibodies exhibiting the highest affinity, solubility and stability all combined with a very low risk of immunogenicity.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0011/0186/110186v1-max-150x150.png"],
     [[250,
       54],
      "assets/images/resized/0011/0186/110186v1-max-250x250.png"],
     [[251,
       55],
      "assets/images/resized/0011/0186/110186v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Executive Chairman",
    "person":
     {"first_name": "Thomas",
      "last_name": "Hecht",
      "permalink": "thomas-hecht",
      "image": null}},
   {"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Eric",
      "last_name": "de la Fortelle",
      "permalink": "eric-de-la-fortelle",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Jakob",
      "last_name": "Schlapbach",
      "permalink": "jakob-schlapbach",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$33.3M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2010/11/delenex-therapeutics-closes-chf135m.html",
    "source_description": "Delenex Therapeutics Closes CHF13.5M Series A Venture Capital Financing Round",
    "raised_amount": 14000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioCapital",
         "permalink": "hbm-biocapital",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0565/50565v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0565/50565v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0565/50565v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioMedinvest",
         "permalink": "biomedinvest",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0005/0483/50483v3-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0005/0483/50483v3-max-250x250.png"],
             [[266,
               44],
              "assets/images/resized/0005/0483/50483v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "VI Partners",
         "permalink": "vi-partners",
         "image":
          {"available_sizes":
            [[[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-150x150.jpg"],
             [[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-250x250.jpg"],
             [[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.finsmes.com/2011/05/delenex-therapeutics-raises-19-3m.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Delenex Therapeutics Raises $19.3M",
    "raised_amount": 19300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo Ventures",
         "permalink": "novo-ventures",
         "image":
          {"available_sizes":
            [[[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioCapital",
         "permalink": "hbm-biocapital",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0565/50565v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0565/50565v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0565/50565v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioMedinvest",
         "permalink": "biomedinvest",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0005/0483/50483v3-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0005/0483/50483v3-max-250x250.png"],
             [[266,
               44],
              "assets/images/resized/0005/0483/50483v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "VI Partners",
         "permalink": "vi-partners",
         "image":
          {"available_sizes":
            [[[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-150x150.jpg"],
             [[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-250x250.jpg"],
             [[117,
               134],
              "assets/images/resized/0005/0484/50484v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Wagistrasse 23",
    "address2": "",
    "zip_code": "CH-8952",
    "city": "Z\u00c3\u00bcrich-Schlieren ",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}